麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

瑞士Genionics
瑞士Genionics成立于2007年.
Genionics is a privately owned Swiss biotech company headquartered in Schlieren at the Biotech Center of Zurich. The company was founded in 2007 by specialists in the fields of ion channel research and molecular biology and is thoroughly experienced in the development stages of modern drug discovery.

Our main focus is on ion channels, pore-forming proteins essential for the trafficking of ions in virtually every living cell. Along with kinases and GPCRs, ion channels belong to three most important drug target classes. The sequencing of the human genome (approximately 400 identified ion channel genes) as well as the advent of automated patch-clamp systems launched the ion channel revolution.

Ion channel analysis has so far not been able to make the leap to High Throughput Screening (HTS). Genionics offers next generation ion channel reagents to widen this bottleneck. Our unique screening concept will facilitate the discovery of new ion channel targets and will effectively open the door to a new frontier of treatments for ion channel diseases.

Products include:

Stable ion channel cells
Ion Channel Allele Screening
Channelopathy Diagnostics
Custom-designed cell lines
?Our vision is to become the centre of excellence for ion channel diseases, so-called channelopathies. We provide you with next generation ion channel tools to accelerate your research projects in drug discovery and diagnosis.

The close linkage of prevention, diagnosis and treatment is a basic prerequisite for the development of new and highly individualized cures to improve patient's quality of life. Genionics actively promotes the paradigm shift from single gene screening to ion channel allele screening. Thereby, we intend to contribute to the current advancement in the area of personalized medicine.

Behind our ion channel cell products stands extensive know-how. Genionics mission is the efficient conversion of our proprietary technology into high-end ion channel tools to establish a comprehensive collection of cell line reagents. Our current products are offered in the ChanClone? catalogue to let you profit from our expertise.

?